Table 2.
Pulmonary Embolism Prevention after HiP and KneE Replacement inferiority margins with observed event rates for both aspirin comparison
| Event rate (%) | Rivaroxaban/aspirin comparison | Warfarin/aspirin comparison | ||
| Absolute difference (%) | Relative difference | Absolute difference (%) | Relative difference | |
| 2.5 | 0.935 | 1.374 | 0.902 | 1.361 |
| 3.0 | 1.023 | 1.341 | 0.984 | 1.328 |
| 3.5 | 1.102 | 1.315 | 1.060 | 1.303 |
*StatisicalAnalysisPlan, ThePEPPERTrial.atwww.PEPPERstudy.org